What is GTI Laboratories?
Founded in 2013, GTI Laboratories operates as a specialized clinical laboratory service provider, delivering a comprehensive suite of diagnostic solutions including toxicology, respiratory pathogen panels, gastrointestinal testing, and infectious disease screening. By maintaining high-compliance facilities in Arizona and Texas, the company has successfully scaled its operations to serve medical professionals across 49 states. Their market position is defined by a commitment to cost-effective, high-accuracy diagnostics, which are essential for facilitating rapid clinical decision-making and improving patient outcomes in a value-based care environment.
How much funding has GTI Laboratories raised?
GTI Laboratories has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in GTI Laboratories
PPP
Public-Private Partnership
What's next for GTI Laboratories?
With this late-stage financing, GTI Laboratories is well-positioned to optimize its laboratory throughput and expand its diagnostic service portfolio. The strategic allocation of this capital will likely focus on enhancing technological integration within their testing workflows and potentially increasing their geographic footprint to capture further market share. As the demand for efficient, decentralized diagnostic services continues to rise, GTI's focus on operational excellence and regulatory compliance will be critical in maintaining its competitive edge and driving long-term enterprise value.
See full GTI Laboratories company page
